Jacobs Levy Equity Management
ANIP icon

Jacobs Levy Equity Management’s ANI Pharmaceuticals ANIP Stock Holding History

Jacobs Levy Equity Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,706
Closed -$215K – 970
2023
Q3 		$215K Sell
3,706
-28,311
-88% -$1.63M ﹤0.01% 918
2023
Q2 		$1.72M Sell
32,017
-3,091
-9% -$137K 0.01% 599
2023
Q1 		$1.39M Buy
+35,108
New +$1.48M 0.01% 637
2014
Q3 		– Sell
-7,759
Closed -$267K – 820
2014
Q2 		$267K Sell
7,759
-1,580
-17% -$49.5K ﹤0.01% 731
2014
Q1 		$293K Buy
+9,339
New +$248K ﹤0.01% 760

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return